|Bid||28.370 x 200|
|Ask||28.380 x 500|
|Day's Range||28.010 - 28.680|
|52 Week Range||10.210 - 31.390|
|PE Ratio (TTM)||-9.31|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Matinas, working on a version of Insmed drug, may now be in a position to duplicate its success
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Insmed, Newlink Genetics, and Voyager Therapeutics stocks soar on positive news.